Skip to main content
Sign In

Charles H. Kirkpatrick, MD - Professor

Division of Allergy & Clinical Immunology

Director, Adult Immunodeficiency Program


12700 E. 19th Avenue, B164, R2
Aurora, CO 80045
Phone: 303-724-7197
Fax: 303-724-7212


1954 BA, Chemistry - University of Kansas, Lawrence, Kansas

1958 MD - University of Kansas School of Medicine, Kansas City Kansas

1958-1959 Internship, University of Illinois Research and educational Hospital, Chicago, IL

1959-1962 Resident in Medicine, University of Kansas Medical Center, Kansas City, KS

1962-1965 Fellowship, University of Colorado Medical Center, Denver, CO


Board Certification:

Internal Medicine

Allergy and Immunology

Clinical applications of the following:

Pathogenesis of immune deficiency diseases

Methods of treatment of immune deficiency diseases

Immunotherapy of persistent viral and fungal infections

Mechanisms of urticaria and angioedema

Allergy and Immunology Practice 


Clinic Location:

University of Colorado Allergy, Immunology and Rheumatology Practice

1635 Aurora Court

6th Floor, Anschutz Outpatient Pavilion

Aurora, CO 80045


Clinic Days:

Tuesday Mornings


Appointment Contact:


For more information please see Dr. Kirkpatrick's profile at

Pathogenesis of immune deficiency diseases.

Methods of treatment of immune deficiency diseases.

Immunotherapy of persistent viral and fungal infections.

Mechanisms of urticaria and angioedema.

Cicardi M, Banerji A, Brancho F, Malbran A, Kirkpatrick CH.  Icatibant.  A new bradykinin receptor antagonist in hereditary angioedema.  New Engl J Med 2010;363:532-541.

Borish L, Ayers AG, Kirkpatrick CH.  Common variable immunodeficiency presenting as herpes simplex virus encephalitis. J Allergy Clin Immunol  2011;127:541-543.
Kirkpatrick CH. A mechanism for urticaria/angioedema in patients with thyroid disease.  J Allergy Clin Immunol  2012;130:988-990.
Zuraw BL, Bork K, Binkley KE, Banerji A, Christianson SC, Costaldo A, Kaplan AP, Riedl M, Kirkpatrick CH, Magerl M, Droiet C , Cicardi M.  Hereditary angioedema with normal C1 inhibitor function: consensus of an international panel.  Allergy Asthma Proc 2012; 33 Suppl 1:145-156.
Malbran A, Riedl M, Ritchie B, Smith WB, Yang W, Banerji A, Hebert L, Gleich GJ,  Kirkpatrick CH, et al. Repeat treatment of acute hereditary angioedema attacks with open-label icatibant in the FAST-1 trial.  Clin Expt Immunol 2014: 177:544-553.